Carpinteria, California (PRWEB) October 22, 2008
NuSil Technology (http://www.nusil.com), a cutting-edge manufacturer of silicone-based materials, and Ciba, a worldwide provider of turnkey antimicrobial solutions to the medical device industry, announce their agreement to jointly provide antimicrobial solutions for use in medical device and healthcare-related silicone products.
It is believed there is an increased risk of infections when microorganisms bind and multiply on the surface of medical devices that are in contact with or inserted into the body. The goal of the collaboration between NuSil and Ciba is to develop customized medical silicone materials incorporated with an innovative microbial defense system that offers built-in broad range spectrum protection against growth of microorganisms ─ specific to any device application needs.
"We are excited to work with Ciba as a strategic partner," said Brian Nash, NuSil Technology's vice president of Marketing and Sales. "Ciba has the technical expertise, a proven record of product efficacy and demonstrated testing capabilities of antimicrobial technology that we can combine with our expertise of silicones for use in long-term implantable devices. The mission of our collaboration with Ciba is to provide a new, unique class of products to help customers develop safe and effective products."
"The collaboration with NuSil complements Ciba's offerings of antimicrobial effects for the medical device industry," said Catherine Ehrenberger, global head of Ciba's Business Line Home & Personal Care. "NuSil's expertise in medical device-related silicone products allows us to jointly develop tailor-made solutions for our customers."
For more information, please visit the NuSil's booth No. 8aL15 and the Ciba's booth No. 8aD16 at the COMPAMED 2008 exposition, to be held Nov.19-21 in Düsseldorf, Germany, or visit http://www.nusil.com and http://www.ciba.com/medicaldevicematerials.
About NuSil Technology
NuSil is a cutting-edge manufacturer of silicone compounds for healthcare, aerospace, electronics, photonics and other applications that require precise, predictable, cost-effective materials performance. NuSil has been providing silicone materials for long-term implantable applications for over two decades. Many of NuSil's products meet Class VI and most ISO-10993 biological testing requirements, and many are supported by a comprehensive Master Access File (MAF) submitted to the United States Food and Drug Administration (FDA). NuSil operates ISO-9001-certified state-of-the-art laboratories and processing facilities in North America and Europe and provides on-site, in-person application engineering support worldwide.
Ciba (SWX:CIBN) is a leading global company dedicated to producing high-value effects for its customers' products. We strive to be the partner of choice for our customers, offering them innovative products and one-stop expert service. We create effects that improve the quality of life - adding performance, protection, color and strength to plastics, paper, automobiles, buildings, home and personal care products and much more. Ciba is active in more than 120 countries around the world and is committed to being a leader in its chosen markets. In 2007, the Company generated sales of CHF 6.5 billion from continued operations and invested over CHF 260 million in R&D.